
Bristows LLP has a comprehensive M&A offering, enabling the team to advise on public and private transactions both domestically and internationally. The group’s wide-ranging capabilities and experience handling high-value and high-profile deals continue to attract new clients to its roster which is comprised of notable names from the technology, healthcare, and retail sectors. Iain Redford sits at the helm of the practice and is sought out for his expertise in technology and life sciences-focused M&A, joint ventures, and financings. He is supported by Marek Petecki who is a key contact for businesses from IP-rich industries seeking assistance with spin-outs and joint ventures. On the cross-border transaction front, David Horner and Nick Cross are names to note, while Richard Swaine concentrates on distressed M&A, and Samuel Munday is adept at acting on both the buy- and sell-side of deals.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘The team are really collaborative and bring in the relevant experts as needed.’
‘They understand our business, appetite to risk, and are commercially savvy so will often bring solutions and challenges that enhance the deal or create a favourable workaround.’
Key clients
- AstraZeneca plc
- WPP plc
Work highlights
Advising UCL Business on the sale of its equity stake in spin-out company Endomag.
Lawyers
Next Generation Partners
Junior partners with significant recognition from clients and peers in the market and key roles on multiple matters.

Leading associates
Leading associates with regular involvement in their team's key work, and recognition from peers or clients as being ones to watch.
Practice head
Iain Redford
Other key lawyers
Marek Petecki; David Horner; Nick Cross; Richard Swaine; Sam Munday

